NIFTY23,3100.45%
SENSEX74,1280.31%
BANKNIFTY54,1820.23%
NIFTY IT28,9681.13%
PHARMA24,2880.46%
AUTO26,1400.02%
FMCG48,1800.08%
METAL13,1801.91%
REALTY768.550.52%
ENERGY40,2680.44%
NIFTY23,3100.45%
SENSEX74,1280.31%
BANKNIFTY54,1820.23%
NIFTY IT28,9681.13%
PHARMA24,2880.46%
AUTO26,1400.02%
FMCG48,1800.08%
METAL13,1801.91%
REALTY768.550.52%
ENERGY40,2680.44%

Market Activity Driven by Corporate Developments and Regulatory Triggers

Several stocks remained in focus on June 5 as corporate developments, earnings announcements, and regulatory triggers continued to drive market activity.

In the midst of this activity, AvenuesAI shares added 2 percent following the Central Bank of the UAE's decision to grant in-principle approval to the company's step-down subsidiary, Avenues World FZ LLC, for a Retail Payment Services – Category III Licence in accordance with the Retail Payment Services and Card Schemes Regulation.

CompanyShare Price Movement
InterGlobe AviationDown marginally
Aurobindo PharmaUp 1.5%
LupinUp 1%
CG PowerHit 52-week high of Rs 952.15

Read also: Meesho Share Price Sees Sudden Reversal After Eight Consecutive Declines, Analysts Predict Further Upside

Shares of InterGlobe Aviation, the parent company of IndiGo, down marginally after the company decided to make temporary adjustments to a limited segment of its international network, including the temporary suspension of operations to Langkawi, Krabi, Ho Chi Minh City, Hong Kong, and Shanghai from July 1, 2026, as well as to Siem Reap from July 3, 2026, until September 30, 2026. IndiGo will resume bookings for all the impacted services starting October 1, 2026.

Lupin's share price rose 1 percent post the United States Food and Drug Administration (U.S. FDA) approval of its ranibizumab, RanluspecTM (ranibizumab-hkdz), as an interchangeable biosimilar referencing to Lucentis (Genentech).

Aurobindo Pharma shares rose 1.5 percent on final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tofacitinib Tablets, 5 mg and 10 mg.

Shares of CG Power hit a 52-week high of Rs 952.15 after the company commissioned its extra-high-voltage (EHV) switchgear manufacturing facility in Nashik, Maharashtra. This is in addition to the S3 Unit-I manufacturing facility at Ambad, Nashik, which manufactures EHV circuit breakers in the 33kV to 800kV range.

Read also: Google Releases Gemma 4 12B, Advanced Multimodal AI Capabilities for 16 GB Laptops

Market participants said that news flow remains a key driver in the current market environment, with investors closely monitoring corporate announcements and sector-specific developments. As the earnings season progresses, company-specific updates are expected to continue driving stock-specific volatility.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.